Investor Moves
News
businesswire.comTakeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)businesswire.comMay 4
defenseworld.netBCS Wealth Management Buys 27,349 Shares of Invesco International Dividend Achievers ETF $PIDdefenseworld.netApr 16